Dexcom Investor
Dexcom's goal is to simplify and improve diabetes management by using Continuous Glucose Management (CGM). Designed to keep track of glucose levels.
Investors
%20.jpg)
%20.jpg)
%20.jpg)
Total Funding:
413689019
Acquisitions Number:
3
Headquarters:
San Diego
Funding Status:
IPO
Employee Number:
7600
Estimated Revenue:
US$ 3.62 billion
Last Funding Type:
Post-IPO Debt
Number Of Exists:
1
Technology:
AgeTech
Investor Type:
For Profit
Last Funding Date:
2017
Investors Number:
7
Founded Date:
1999-05-22
Industry:
manufacturing